-

$undefined

N/A

(N/A)

Solid Biosciences NASDAQ:SLDB

Location: | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

72.86M

Cash

148.9M

Avg Qtr Burn

-25.0M

Short % of Float

21.95%

Insider Ownership

0.70%

Institutional Own.

65.68%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SGT-003 Details Genetic disorder, Duchenne muscular dystrophy	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-212 (dual route) Details Friedreich’s Ataxia	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-501 (Cardiac Gene Therapy) Details Catecholaminergic Polymorphic Ventricular Tachycardia, Heart disease, Gene & Cell therapies	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SGT-001 (Microdystrophin Gene Transfer) Details Genetic disorder, Muscle weakness, Muscle degeneration	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.